Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O6ZH
|
|||
Drug Name |
Endo-CD
|
|||
Synonyms |
Endostatin-cytosine deaminase fusion protein
Click to Show/Hide
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Endostatin (COL18A1) | Target Info | Modulator | [1] |
KEGG Pathway | Protein digestion and absorption | |||
NetPath Pathway | FSH Signaling Pathway | |||
Pathway Interaction Database | Beta1 integrin cell surface interactions | |||
Direct p53 effectors | ||||
Validated nuclear estrogen receptor alpha network | ||||
FOXA1 transcription factor network | ||||
Reactome | Collagen degradation | |||
Activation of Matrix Metalloproteinases | ||||
Collagen biosynthesis and modifying enzymes | ||||
Assembly of collagen fibrils and other multimeric structures | ||||
Integrin cell surface interactions | ||||
Laminin interactions | ||||
WikiPathways | Assembly of collagen fibrils and other multimeric structures | |||
Activation of Matrix Metalloproteinases | ||||
Collagen biosynthesis and modifying enzymes |
References | Top | |||
---|---|---|---|---|
REF 1 | Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase.Mol Cancer Ther.2011 Aug;10(8):1327-36. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.